Chinese General Practice ›› 2023, Vol. 26 ›› Issue (30): 3740-3747.DOI: 10.12114/j.issn.1007-9572.2023.0168
• Original Research • Previous Articles Next Articles
Received:
2023-02-11
Revised:
2023-05-26
Published:
2023-10-20
Online:
2023-05-26
Contact:
ZHANG Xiangyang
通讯作者:
张向阳
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0168
组别 | 例数 | 年龄(岁) | 性别〔例(%)〕 | 吸烟〔例(%)〕 | 饮酒〔例(%)〕 | 身高(cm) | 体质量(kg) | BMI(kg/m2) | 颈围(cm) | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
女 | 男 | 无 | 有 | 无 | 有 | |||||||
非OSA组 | 657 | 44.9±11.0 | 307(46.7) | 350(53.3) | 412(62.7) | 245(37.3) | 425(64.7) | 232(35.3) | 168.35±8.05 | 79.58±13.94 | 28.0±4.1 | 39.56±3.77 |
OSA组 | 2 193 | 49.7±10.8 | 685(31.2) | 1 508(68.8) | 1 306(59.6) | 887(40.4) | 1 357(61.9) | 836(38.1) | 169.28±7.97 | 80.45±13.43 | 28.0±3.8 | 40.03±3.85 |
检验统计量值 | -9.96b | 52.79a | 1.97a | 1.58a | 2.61b | -1.45b | 0.01b | -2.72b | ||||
P值 | <0.001 | <0.001 | 0.160 | 0.208 | 0.009 | 0.146 | 0.994 | 0.006 | ||||
组别 | 腰围(cm) | 收缩压(mmHg) | 舒张压(mmHg) | TC〔M(P25,P75),mmol/L〕 | TG〔M(P25,P75),mmol/L〕 | HDL-C〔M(P25,P75),mmol/L〕 | LDL-C〔M(P25,P75),mmol/L〕 | AHI〔M(P25,P75),次/h〕 | 睡眠有效率〔M(P25,P75),%〕 | |||
非OSA组 | 99.14±10.79 | 140±20 | 91±14 | 4.43(3.76,4.96) | 1.42(1.05,2.01) | 1.12(0.94,1.32) | 2.59(2.00,3.08) | 1.7(0.7,3.1) | 70.9(61.7,79.4) | |||
OSA组 | 99.60±10.65 | 134±19 | 92±14 | 4.47(3.87,5.10) | 1.76(1.28,2.48) | 1.06(0.90,1.25) | 2.59(2.11,3.12) | 18.7(10.3,33.8) | 71.2(61.7,79.3) | |||
检验统计量值 | -0.98b | 0.50b | -1.21b | -2.35c | -8.95c | -4.84c | -1.43c | -38.94c | -0.30c | |||
P值 | 0.328 | 0.615 | 0.226 | 0.019 | <0.001 | <0.001 | 0.153 | <0.001 | 0.767 | |||
组别 | 总睡眠时间〔M(P25,P75),min〕 | 平均SaO2〔M(P25,P75),%〕 | 最低SaO2〔M(P25,P75),%〕 | CVAI〔M(P25,P75)〕 | AIP〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | LAP〔M(P25,P75)〕 | VAI〔M(P25,P75)〕 | ||||
非OSA组 | 376.0(324.0,419.0) | 94(93,95) | 88(87,90) | 111.05(86.07,138.83) | 0.13(-0.06,0.32) | 0.75(0.48,1.18) | 52.80(34.40,79.10) | 2.08(1.37,3.23) | ||||
OSA组 | 373.5(325.5,415.5) | 92(91,94) | 80(75,84) | 145.09(119.88,171.53) | 0.22(0.04,0.41) | 1.00(0.64,1.55) | 64.35(42.90,98.70) | 2.64(1.74,4.06) | ||||
检验统计量值 | -0.73c | -21.70c | -34.29c | -17.77c | -7.24c | -9.01c | -7.32c | -8.37c | ||||
P值 | 0.464 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of clinical data between the two groups of patients
组别 | 例数 | 年龄(岁) | 性别〔例(%)〕 | 吸烟〔例(%)〕 | 饮酒〔例(%)〕 | 身高(cm) | 体质量(kg) | BMI(kg/m2) | 颈围(cm) | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
女 | 男 | 无 | 有 | 无 | 有 | |||||||
非OSA组 | 657 | 44.9±11.0 | 307(46.7) | 350(53.3) | 412(62.7) | 245(37.3) | 425(64.7) | 232(35.3) | 168.35±8.05 | 79.58±13.94 | 28.0±4.1 | 39.56±3.77 |
OSA组 | 2 193 | 49.7±10.8 | 685(31.2) | 1 508(68.8) | 1 306(59.6) | 887(40.4) | 1 357(61.9) | 836(38.1) | 169.28±7.97 | 80.45±13.43 | 28.0±3.8 | 40.03±3.85 |
检验统计量值 | -9.96b | 52.79a | 1.97a | 1.58a | 2.61b | -1.45b | 0.01b | -2.72b | ||||
P值 | <0.001 | <0.001 | 0.160 | 0.208 | 0.009 | 0.146 | 0.994 | 0.006 | ||||
组别 | 腰围(cm) | 收缩压(mmHg) | 舒张压(mmHg) | TC〔M(P25,P75),mmol/L〕 | TG〔M(P25,P75),mmol/L〕 | HDL-C〔M(P25,P75),mmol/L〕 | LDL-C〔M(P25,P75),mmol/L〕 | AHI〔M(P25,P75),次/h〕 | 睡眠有效率〔M(P25,P75),%〕 | |||
非OSA组 | 99.14±10.79 | 140±20 | 91±14 | 4.43(3.76,4.96) | 1.42(1.05,2.01) | 1.12(0.94,1.32) | 2.59(2.00,3.08) | 1.7(0.7,3.1) | 70.9(61.7,79.4) | |||
OSA组 | 99.60±10.65 | 134±19 | 92±14 | 4.47(3.87,5.10) | 1.76(1.28,2.48) | 1.06(0.90,1.25) | 2.59(2.11,3.12) | 18.7(10.3,33.8) | 71.2(61.7,79.3) | |||
检验统计量值 | -0.98b | 0.50b | -1.21b | -2.35c | -8.95c | -4.84c | -1.43c | -38.94c | -0.30c | |||
P值 | 0.328 | 0.615 | 0.226 | 0.019 | <0.001 | <0.001 | 0.153 | <0.001 | 0.767 | |||
组别 | 总睡眠时间〔M(P25,P75),min〕 | 平均SaO2〔M(P25,P75),%〕 | 最低SaO2〔M(P25,P75),%〕 | CVAI〔M(P25,P75)〕 | AIP〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | LAP〔M(P25,P75)〕 | VAI〔M(P25,P75)〕 | ||||
非OSA组 | 376.0(324.0,419.0) | 94(93,95) | 88(87,90) | 111.05(86.07,138.83) | 0.13(-0.06,0.32) | 0.75(0.48,1.18) | 52.80(34.40,79.10) | 2.08(1.37,3.23) | ||||
OSA组 | 373.5(325.5,415.5) | 92(91,94) | 80(75,84) | 145.09(119.88,171.53) | 0.22(0.04,0.41) | 1.00(0.64,1.55) | 64.35(42.90,98.70) | 2.64(1.74,4.06) | ||||
检验统计量值 | -0.73c | -21.70c | -34.29c | -17.77c | -7.24c | -9.01c | -7.32c | -8.37c | ||||
P值 | 0.464 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
变量 | 区间 | B | SE | Wald χ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|---|---|
AIP | Q1(<0.01) | 50.356 | |||||
Q2(0.01~0.20) | 0.337 | 0.119 | 8.071 | 1.401 | (1.110,1.767) | 0.004 | |
Q3(0.21~0.39) | 0.639 | 0.124 | 26.469 | 1.896 | (1.486,2.418) | <0.001 | |
Q4(>0.39) | 0.838 | 0.129 | 42.075 | 2.311 | (1.794,2.976) | <0.001 | |
VAI | Q1(<1.64) | 63.619 | |||||
Q2(1.64~2.49) | 0.432 | 0.118 | 13.281 | 1.540 | (1.221,1.942) | <0.001 | |
Q3(2.50~3.86) | 0.713 | 0.124 | 33.100 | 2.040 | (1.600,2.600) | <0.001 | |
Q4(>3.86) | 0.954 | 0.130 | 53.855 | 2.595 | (2.012,3.348) | <0.001 | |
LAP | Q1(<40.56) | 52.971 | |||||
Q2(40.56~61.40) | 0.425 | 0.120 | 12.668 | 1.530 | (1.211,1.934) | <0.001 | |
Q3(61.41~94.07) | 0.555 | 0.122 | 20.718 | 1.742 | (1.372,2.212) | <0.001 | |
Q4(>94.07) | 0.919 | 0.131 | 49.523 | 2.507 | (1.941,3.239) | <0.001 | |
CMI | Q1(<0.60) | 68.556 | |||||
Q2(0.60~0.94) | 0.372 | 0.118 | 10.018 | 1.451 | (1.152,1.827) | 0.002 | |
Q3(0.95~1.48) | 0.706 | 0.124 | 32.481 | 2.027 | (1.590,2.584) | <0.001 | |
Q4(>1.48) | 1.012 | 0.132 | 58.902 | 2.750 | (2.124,3.561) | <0.001 | |
CVAI | Q1(<109.82) | 275.337 | |||||
Q2(109.82~137.85) | 1.020 | 0.116 | 76.797 | 2.773 | (2.208,3.484) | <0.001 | |
Q3(137.86~167.21) | 1.587 | 0.130 | 148.872 | 4.890 | (3.789,6.310) | <0.001 | |
Q4(>167.21) | 2.135 | 0.151 | 199.595 | 8.455 | (6.288,11.369) | <0.001 |
Table 2 Univariate Logistic analysis of the association between quartiles of five metabolic indexes and OSA
变量 | 区间 | B | SE | Wald χ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|---|---|
AIP | Q1(<0.01) | 50.356 | |||||
Q2(0.01~0.20) | 0.337 | 0.119 | 8.071 | 1.401 | (1.110,1.767) | 0.004 | |
Q3(0.21~0.39) | 0.639 | 0.124 | 26.469 | 1.896 | (1.486,2.418) | <0.001 | |
Q4(>0.39) | 0.838 | 0.129 | 42.075 | 2.311 | (1.794,2.976) | <0.001 | |
VAI | Q1(<1.64) | 63.619 | |||||
Q2(1.64~2.49) | 0.432 | 0.118 | 13.281 | 1.540 | (1.221,1.942) | <0.001 | |
Q3(2.50~3.86) | 0.713 | 0.124 | 33.100 | 2.040 | (1.600,2.600) | <0.001 | |
Q4(>3.86) | 0.954 | 0.130 | 53.855 | 2.595 | (2.012,3.348) | <0.001 | |
LAP | Q1(<40.56) | 52.971 | |||||
Q2(40.56~61.40) | 0.425 | 0.120 | 12.668 | 1.530 | (1.211,1.934) | <0.001 | |
Q3(61.41~94.07) | 0.555 | 0.122 | 20.718 | 1.742 | (1.372,2.212) | <0.001 | |
Q4(>94.07) | 0.919 | 0.131 | 49.523 | 2.507 | (1.941,3.239) | <0.001 | |
CMI | Q1(<0.60) | 68.556 | |||||
Q2(0.60~0.94) | 0.372 | 0.118 | 10.018 | 1.451 | (1.152,1.827) | 0.002 | |
Q3(0.95~1.48) | 0.706 | 0.124 | 32.481 | 2.027 | (1.590,2.584) | <0.001 | |
Q4(>1.48) | 1.012 | 0.132 | 58.902 | 2.750 | (2.124,3.561) | <0.001 | |
CVAI | Q1(<109.82) | 275.337 | |||||
Q2(109.82~137.85) | 1.020 | 0.116 | 76.797 | 2.773 | (2.208,3.484) | <0.001 | |
Q3(137.86~167.21) | 1.587 | 0.130 | 148.872 | 4.890 | (3.789,6.310) | <0.001 | |
Q4(>167.21) | 2.135 | 0.151 | 199.595 | 8.455 | (6.288,11.369) | <0.001 |
变量 | 区间 | B | SE | Waldχ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|---|---|
AIP | Q1(<0.01) | 36.963 | |||||
Q2(0.01~0.20) | 0.358 | 0.127 | 7.960 | 1.430 | (1.115,1.833) | 0.005 | |
Q3(0.21~0.39) | 0.627 | 0.134 | 21.831 | 1.871 | (1.439,2.434) | <0.001 | |
Q4(>0.39) | 0.807 | 0.144 | 31.330 | 2.241 | (1.689,2.972) | <0.001 | |
VAI | Q1(<1.64) | 51.455 | |||||
Q2(1.64~2.49) | 0.431 | 0.125 | 11.920 | 1.539 | (1.205,1.966) | 0.001 | |
Q3(2.50~3.86) | 0.689 | 0.131 | 27.596 | 1.991 | (1.540,2.574) | <0.001 | |
Q4(>3.86) | 0.923 | 0.138 | 44.520 | 2.517 | (1.919,3.301) | <0.001 | |
LAP | Q1(<40.56) | 38.276 | |||||
Q2(40.56~61.40) | 0.391 | 0.126 | 9.707 | 1.479 | (1.156,1.891) | 0.002 | |
Q3(61.41~94.07) | 0.505 | 0.129 | 15.284 | 1.658 | (1.287,2.136) | <0.001 | |
Q4(>94.07) | 0.839 | 0.139 | 36.344 | 2.313 | (1.761,3.038) | <0.001 | |
CMI | Q1(<0.60) | 54.294 | |||||
Q2(0.60~0.94) | 0.388 | 0.125 | 9.620 | 1.474 | (1.154,1.885) | 0.002 | |
Q3(0.95~1.48) | 0.702 | 0.133 | 27.786 | 2.018 | (1.554,2.620) | <0.001 | |
Q4(>1.48) | 1.005 | 0.145 | 47.721 | 2.732 | (2.054,3.633) | <0.001 | |
CVAI | Q1(<109.82) | 157.831 | |||||
Q2(109.82~137.85) | 0.807 | 0.122 | 44.017 | 2.242 | (1.766,2.846) | <0.001 | |
Q3(137.86~167.21) | 1.304 | 0.138 | 89.050 | 3.683 | (2.810,4.829) | <0.001 | |
Q4(>167.21) | 1.802 | 0.162 | 123.676 | 6.060 | (4.411,8.324) | <0.001 |
Table 3 Multivariate Logistic analysis of the association between quartiles of 5 metabolic indexes and OSA
变量 | 区间 | B | SE | Waldχ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|---|---|
AIP | Q1(<0.01) | 36.963 | |||||
Q2(0.01~0.20) | 0.358 | 0.127 | 7.960 | 1.430 | (1.115,1.833) | 0.005 | |
Q3(0.21~0.39) | 0.627 | 0.134 | 21.831 | 1.871 | (1.439,2.434) | <0.001 | |
Q4(>0.39) | 0.807 | 0.144 | 31.330 | 2.241 | (1.689,2.972) | <0.001 | |
VAI | Q1(<1.64) | 51.455 | |||||
Q2(1.64~2.49) | 0.431 | 0.125 | 11.920 | 1.539 | (1.205,1.966) | 0.001 | |
Q3(2.50~3.86) | 0.689 | 0.131 | 27.596 | 1.991 | (1.540,2.574) | <0.001 | |
Q4(>3.86) | 0.923 | 0.138 | 44.520 | 2.517 | (1.919,3.301) | <0.001 | |
LAP | Q1(<40.56) | 38.276 | |||||
Q2(40.56~61.40) | 0.391 | 0.126 | 9.707 | 1.479 | (1.156,1.891) | 0.002 | |
Q3(61.41~94.07) | 0.505 | 0.129 | 15.284 | 1.658 | (1.287,2.136) | <0.001 | |
Q4(>94.07) | 0.839 | 0.139 | 36.344 | 2.313 | (1.761,3.038) | <0.001 | |
CMI | Q1(<0.60) | 54.294 | |||||
Q2(0.60~0.94) | 0.388 | 0.125 | 9.620 | 1.474 | (1.154,1.885) | 0.002 | |
Q3(0.95~1.48) | 0.702 | 0.133 | 27.786 | 2.018 | (1.554,2.620) | <0.001 | |
Q4(>1.48) | 1.005 | 0.145 | 47.721 | 2.732 | (2.054,3.633) | <0.001 | |
CVAI | Q1(<109.82) | 157.831 | |||||
Q2(109.82~137.85) | 0.807 | 0.122 | 44.017 | 2.242 | (1.766,2.846) | <0.001 | |
Q3(137.86~167.21) | 1.304 | 0.138 | 89.050 | 3.683 | (2.810,4.829) | <0.001 | |
Q4(>167.21) | 1.802 | 0.162 | 123.676 | 6.060 | (4.411,8.324) | <0.001 |
预测变量 | AUC | 95%CI | 截断值 | 灵敏度(%) | 特异度(%) | 约登指数 |
---|---|---|---|---|---|---|
TC | 0.530 | (0.505,0.555) | 5.265 | 20.5 | 84.9 | 0.054 |
TG | 0.615 | (0.590,0.640) | 1.425 | 67.7 | 50.8 | 0.186 |
HDL-C | 0.562 | (0.537,0.588) | 1.175 | 66.8 | 43.1 | 0.099 |
LDL-C | 0.518 | (0.493,0.544) | 1.955 | 81.4 | 23.7 | 0.051 |
AIP | 0.593 | (0.568,0.618) | 0.152 | 60.4 | 54.6 | 0.150 |
VAI | 0.607 | (0.583,0.632) | 2.365 | 57.3 | 58.8 | 0.160 |
LAP | 0.594 | (0.569,0.619) | 46.030 | 70.9 | 43.1 | 0.140 |
CMI | 0.616 | (0.591,0.640) | 0.825 | 61.5 | 57.1 | 0.186 |
CVAI | 0.728 | (0.706,0.751) | 125.265 | 70.8 | 65.4 | 0.362 |
Table 4 Receiver operating characteristic curve of lipid parameters and metabolic indexes in predicting OSA
预测变量 | AUC | 95%CI | 截断值 | 灵敏度(%) | 特异度(%) | 约登指数 |
---|---|---|---|---|---|---|
TC | 0.530 | (0.505,0.555) | 5.265 | 20.5 | 84.9 | 0.054 |
TG | 0.615 | (0.590,0.640) | 1.425 | 67.7 | 50.8 | 0.186 |
HDL-C | 0.562 | (0.537,0.588) | 1.175 | 66.8 | 43.1 | 0.099 |
LDL-C | 0.518 | (0.493,0.544) | 1.955 | 81.4 | 23.7 | 0.051 |
AIP | 0.593 | (0.568,0.618) | 0.152 | 60.4 | 54.6 | 0.150 |
VAI | 0.607 | (0.583,0.632) | 2.365 | 57.3 | 58.8 | 0.160 |
LAP | 0.594 | (0.569,0.619) | 46.030 | 70.9 | 43.1 | 0.140 |
CMI | 0.616 | (0.591,0.640) | 0.825 | 61.5 | 57.1 | 0.186 |
CVAI | 0.728 | (0.706,0.751) | 125.265 | 70.8 | 65.4 | 0.362 |
[1] |
|
[2] |
中华医学会呼吸分会睡眠呼吸障碍学组,中国医学装备协会呼吸病学装备技术专业委员会睡眠呼吸设备学组. 成人阻塞性睡眠呼吸暂停高危人群筛查与管理专家共识[J]. 中华健康管理学杂志,2022,16(8):520-528. DOI:10.3760/cma.j.cn115624-20220615-00460.
|
[3] |
王云,何燕,刘师节,等. 阻塞性睡眠呼吸暂停低通气综合征与糖脂代谢紊乱的机制研究进展[J]. 中国全科医学,2022,25(2):243-247. DOI:10.12114/j.issn.1007-9572.2021.01.311.
|
[4] |
|
[5] |
|
[6] |
|
[7] |
于悦,谭慧文,刘奕姝,等. 阻塞性睡眠呼吸暂停低通气综合征病情严重程度的影响因素及代谢相关激素与临床相关指标的关系研究[J]. 中国全科医学,2021,24(8):947-953. DOI:10.12114/j.issn.1007-9572.2021.00.142.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[1] | BAI Haiwei, MI Xiaokun, LIU Qingrui, ZHU Lin, WANG Yingnan, LIU Junyan, HAN Ying. Predictive Value of Serum Uric Acid in Perioperative Acute Ischemic Stroke in Patients with Non-small Cell Lung Cancer [J]. Chinese General Practice, 2023, 26(36): 4545-4551. |
[2] | LIANG Xiaoxian, YANG Jin, JIN Juzhen, ZHOU Jing, HU Jin, GAI Yun, DING Xiaoyun, WANG Junhua, WANG Ziyun. Association between Chronotype and Dyslipidemia among Population Aged 40-65 Years [J]. Chinese General Practice, 2023, 26(34): 4277-4282. |
[3] | WANG Yu, CHEN Yan, HAN Yuanyuan, XU Qing, CHEN Shengyue, LYU Zhibo, LU Chuan, ZHENG Mingxin, ZHAO Xin. Platelet-lymphocyte Ratio Predicts In-hospital Mortality in Elderly Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(33): 4137-4142. |
[4] | ZHANG Jifang, CHEN Fang, TANG Jiawen, LI Hongliang. Predictive Value of Tumor Budding and Tumor-infiltrating Lymphocytes on Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma [J]. Chinese General Practice, 2023, 26(32): 4038-4042. |
[5] | HE Yingmei, JIA Xue, ZHU Guojun, LIU Bing. Effect of Serum Uric Acid Longitudinal Trajectory on New-onset Hypertriglyceridemia: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(29): 3636-3639. |
[6] | HUANG Qixian, WEN Yanting, HUANG Jun, LI Weibin, XU Yongneng, LIN Xiayi, WANG Haoxiang, WENG Fan, YANG Lianping. Prevalence of Dyslipidemia and Its Influencing Factors among Elderly Community Residents [J]. Chinese General Practice, 2023, 26(28): 3520-3525. |
[7] | BIAN Lili, LI Xiaoxiao, DU Xueping, DAI Qinfang, WU Lin, SONG Beibei. Risk Stratification of Atherosclerotic Cardiovascular Disease and Lipid Goal Attainment in Hypertensive Patients Registered in Community [J]. Chinese General Practice, 2023, 26(27): 3388-3391. |
[8] | ZHOU Shiyu, CHEN Shaolin, DENG Renli, DAI Mi, LIU Tao, TIAN Kunming. The Association and Predictive Value of Lipid Ratios to Metabolic Syndrome: a Multistage Cross-sectional Study [J]. Chinese General Practice, 2023, 26(21): 2589-2596. |
[9] | HE Manlan, YUAN Ping, HE Lei, CHEN Lu. Meta-analysis of Risk Factors for Urinary Tract Infection in Neurogenic Bladder [J]. Chinese General Practice, 2023, 26(21): 2659-2665. |
[10] | ZHAI Leilei, ZHAO Shupeng, YAO Ping. Meta-analysis of the Relationship between Dietary Inflammatory Index and Upper Gastrointestinal Cancer Risks [J]. Chinese General Practice, 2023, 26(18): 2286-2292. |
[11] | FENG Shuidong, LI Junyan, DENG Shuxiang, CHEN Limou, CAO Mengyue, TANG Yan, TANG Peng, LIU Jun, SHEN Minxue, YANG Fei. Association between Air Pollutant Exposure and Dyslipidemia in Middle-aged and Elderly People in Mining Areas [J]. Chinese General Practice, 2023, 26(18): 2238-2244. |
[12] | WANG Hai, WANG Zhuoli, PEI Honghong, PAN Longfei. Analysis of Risk Factors and Exploration of Predictors of Serious Cases of COVID-19 in Xi'an during the Period of 2021-2022 [J]. Chinese General Practice, 2023, 26(17): 2132-2137. |
[13] | LIANG Shanshan, ZHOU Zhihua, LI Chengcheng, CHEN Huijing, ZHOU Shangcheng. Diabetes in China: Burden Analysis between 1990 and 2019 and Incidence Prediction between 2020 and 2030 [J]. Chinese General Practice, 2023, 26(16): 2013-2019. |
[14] | CHEN Yijia, QI Shengxiang, DU Jinling, WANG Chenchen, ZHOU Hairong, YE Qing, QIN Zhenzhen, SU Jian, WU Ming, HONG Xin. Predictive Value of Cardiometabolic Index for Metabolically Obese Phenotype in Normal Weight Population [J]. Chinese General Practice, 2023, 26(14): 1716-1725. |
[15] | ZHANG Yutong, WANG Qiuqin, XU Yuchen, WENG Heng, LIANG Yongqi, WANG Lulu, WANG Qing, XU Guihua. Factors Affecting Pain in Patients with Parkinson's Disease: a Systematic Review [J]. Chinese General Practice, 2023, 26(14): 1766-1774. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||